Sacyr Balance Sheet Health

Financial Health criteria checks 4/6

Sacyr has a total shareholder equity of €1.8B and total debt of €8.5B, which brings its debt-to-equity ratio to 487.1%. Its total assets and total liabilities are €17.3B and €15.6B respectively. Sacyr's EBIT is €1.3B making its interest coverage ratio 1.7. It has cash and short-term investments of €1.8B.

Key information

487.1%

Debt to equity ratio

€8.52b

Debt

Interest coverage ratio1.7x
Cash€1.77b
Equity€1.75b
Total liabilities€15.56b
Total assets€17.31b

Recent financial health updates

Recent updates

Sacyr (BME:SCYR) Use Of Debt Could Be Considered Risky

Apr 18
Sacyr (BME:SCYR) Use Of Debt Could Be Considered Risky

Is There Now An Opportunity In Sacyr, S.A. (BME:SCYR)?

Mar 06
Is There Now An Opportunity In Sacyr, S.A. (BME:SCYR)?

What Does Sacyr, S.A.'s (BME:SCYR) Share Price Indicate?

Sep 08
What Does Sacyr, S.A.'s (BME:SCYR) Share Price Indicate?

Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

Aug 18
Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

Sacyr (BME:SCYR) Takes On Some Risk With Its Use Of Debt

May 11
Sacyr (BME:SCYR) Takes On Some Risk With Its Use Of Debt

Is It Too Late To Consider Buying Sacyr, S.A. (BME:SCYR)?

Mar 22
Is It Too Late To Consider Buying Sacyr, S.A. (BME:SCYR)?

Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

Feb 10
Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

Is Sacyr, S.A. (BME:SCYR) Trading At A 29% Discount?

Dec 01
Is Sacyr, S.A. (BME:SCYR) Trading At A 29% Discount?

Sacyr, S.A. (BME:SCYR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 10
Sacyr, S.A. (BME:SCYR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

Aug 02
Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

Sacyr's (BME:SCYR) Upcoming Dividend Will Be Larger Than Last Year's

Jun 02
Sacyr's (BME:SCYR) Upcoming Dividend Will Be Larger Than Last Year's

Is Sacyr (BME:SCYR) A Risky Investment?

Oct 19
Is Sacyr (BME:SCYR) A Risky Investment?

Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

Jul 14
Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

Robust Earnings May Not Tell The Whole Story For Sacyr (BME:SCYR)

Mar 06
Robust Earnings May Not Tell The Whole Story For Sacyr (BME:SCYR)

An Intrinsic Calculation For Sacyr, S.A. (BME:SCYR) Suggests It's 41% Undervalued

Feb 19
An Intrinsic Calculation For Sacyr, S.A. (BME:SCYR) Suggests It's 41% Undervalued

How Many Sacyr, S.A. (BME:SCYR) Shares Do Institutions Own?

Jan 20
How Many Sacyr, S.A. (BME:SCYR) Shares Do Institutions Own?

Have Insiders Been Selling Sacyr, S.A. (BME:SCYR) Shares?

Dec 24
Have Insiders Been Selling Sacyr, S.A. (BME:SCYR) Shares?

What Type Of Returns Would Sacyr's(BME:SCYR) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 02
What Type Of Returns Would Sacyr's(BME:SCYR) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Financial Position Analysis

Short Term Liabilities: SCYR's short term assets (€6.9B) exceed its short term liabilities (€6.3B).

Long Term Liabilities: SCYR's short term assets (€6.9B) do not cover its long term liabilities (€9.2B).


Debt to Equity History and Analysis

Debt Level: SCYR's net debt to equity ratio (385.9%) is considered high.

Reducing Debt: SCYR's debt to equity ratio has reduced from 517.1% to 487.1% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable SCYR has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: SCYR is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 15% per year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.